Reducing the Burden of HPV-associated Cancer and Disease through Vaccination in the US
Presented on .
This session of Grand Rounds explored the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination.
HPV is the most common sexually transmitted infection in the United States. There are more than 40 HPV types, some of which cause cancers and others which cause genital warts. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease. Currently available HPV vaccines prevent infection from the HPV types that cause about 70% of cervical cancers and the majority of other HPV-attributable cancers. HPV vaccine has been recommended for routine vaccination of 11-12 year-old girls since 2006 and for 11-12 year-old boys since 2011.
This session also provided more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.
Lauri E. Markowitz, MD, highlights how providers can help:
- Send reminders to parents and patients that they need to come back for the next vaccine
- Arrange for “quick visits” – come in, get vaccine and leave – no appointment necessary
- Let parents and teens know that this is an anti-cancer vaccine – safe and effective
- CAPT Mona Saraiya, MD, MPH
- Medical Officer and Assistant Director for Global Cancer,
Division of Cancer Prevention and Control
National Center for Chronic Disease Prevention and Health Promotion, CDC
- CAPT Eileen F. Dunne, MD, MPH
- Medical Epidemiologist, Epidemiology and Statistics Branch,
Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
- Shannon Stokley, MPH
- Acting Associate Director of Science, Immunization Services Division
Team Lead, Adolescent Vaccination Team
National Center for Immunization and Respiratory Diseases, CDC
- Amy Middleman, MD, MSEd, MPH
- Assistant Professor, Adolescent Medicine Section
Baylor College of Medicine
- Lauri E. Markowitz, MD
- Team Lead, Epidemiology and Statistics Branch, Division of STD Prevention
National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC
- Tanja Popovic, MD, PhD
- Scientific Director
- John Iskander, MD, MPH
- Deputy Scientific Director
- Susan Laird, MSN, RN
- Communications Director
Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!
Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up
Childhood infectious diseases can lead to complications, disability, and death. Protecting all children from vaccine-preventable diseases is a public mandate, requiring the elimination of disparities that put some children at higher risk. Find out how immunization programs positively affect children’s health.